Cowen Raises Price Target on CVS Health (CVS) Following Investor Meetings
Tweet Send to a Friend
Cowen reiterates an Outperform rating on CVS Health (NYSE: CVS), and raised the price target to $116.00 (from $108.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
